Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Enovis Corporation

Enovis Corporation (ENOV) Stock Overview

Explore Enovis Corporation’s financial performance, market position, analyst ratings, and future outlook.

ENOV●NYSE
HealthcareMedical - Devices
$27.03
$0.97(3.72%)
U.S. Market opens in 63h 26m

Enovis Corporation (ENOV)

Meyka AI Score

Z

Key Financials

Market Cap1.6B
P/E Ratio-1.34
EPS (TTM)$3.38
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$29.56
3 Months$23.02
1 Year Target$13.88

ENOV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Enovis Corporation (NYSE: ENOV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Enovis Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ENOV on the NYSE shows an RSI of 58.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $13.88 for the NYSE listing.

Key metrics behind Enovis Corporation's NYSE-traded stock include a P/E ratio of -1.34 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ENOV on the NYSE.

Price Performance (NYSE: ENOV)

1-Day Change
3.80%
5-Day Change
-2.42%
1-Month Change
26.52%
3-Month Change
12.24%
6-Month Change
17.56%
Year-to-Date (YTD) Change
1.54%
1-Year Change
-0.41%
3-Year Change
-57.77%
5-Year Change
-65.40%
All-Time (Max) Change
-25.16%

Contact Information

https://www.enovis.com
302 252 9190
2711 Centerville Road, Wilmington, DE, 19808

Company Facts

78,020 Employees
IPO DateMay 8, 2008
CountryUS
Actively Trading

Frequently Asked Questions